The addition of KPV provides enhanced anti-inflammatory and immune-modulating benefits, making KLOW the preferred choice for those dealing with inflammatory conditions, gut issues, or autoimmune-related symptoms alongside their healing and recovery goals
Chemical Biology & Drug Design, 81(1), 136-147
- Bioactivity drops from 100 percent to near zero
at 4mg per administration, roughly 20
Subcutaneous administration near the injury site provides both high local concentration and some systemic distribution as the peptide migrates to areas of damage throughout the body
The pre-measured capsule format also provides improved dosing accuracy for oral administration studies, reducing the variability that can arise from manual preparation of oral solutions